|
|
|
|
-dependent fashion
1 Department of Biological Chemistry 2 Department of Dermatology, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
| Abstract |
|---|
|
|
|---|
. K17 interacts with TNF receptor 1 (TNFR1)-associated death domain protein (TRADD), a death adaptor essential for TNFR1-dependent signal relay, suggesting a functional link between this keratin and TNF
signaling. The activity of NF-
B, a downstream target of TNF
, is increased in K17-null skin. We also find that TNF
is required for a timely anagencatagen transition in mouse pelage follicles, and that its ablation partially rescues the hair cycling defect of K17-null mice. These findings identify K17 and TNF
as two novel and interdependent regulators of hair cycling.
[Keywords: Intermediate filament; hair cycle; apoptosis; anagen; catagen]
Received October 21, 2005; revised version accepted March 13, 2006.
A mature hair follicle comprises eight distinct epithelial layers organized in concentric circles around the main axis of the hair. These layers form three major compartments: the innermost hair shaft, the inner root sheath (IRS), and the outer root sheath (ORS) (Fig. 1A). During anagen, matrix epithelial cells in the prominent hair bulb proliferate rapidly, giving rise to progenitors for the layers comprising the hair shaft and IRS (Paus and Cotsarelis 1999
; Fuchs et al. 2001
; Millar 2002
). The hair bulb and proximal region above it are destroyed via apoptosis during catagen, producing a short, quiescent telogen hair (Fig. 1A). The mesenchymal dermal papilla is spared from apoptosis, and migrates upward during catagen to maintain physical proximity with the bulge, a local swelling of the ORS that houses a significant fraction of skin epithelial stem cells (Fig. 1A; Paus and Cotsarelis 1999
; Fuchs et al. 2001
; Millar 2002
). Anagen re-entry requires the action of a papilla-derived signal (Hardy 1992
) that causes bulge epithelial stem cells to proliferate, migrate downward, and differentiate de novo.
|
family members (including bone morphogenetic proteins or BMPs), and others, also operate at the time of anagen re-entry in adult skin (Millar 2002
1 (Foitzik et al. 2000
(Hirota et al. 2002
Unlike their wild-type littermates, mice null for the type I keratin 17 (K17) gene fail to develop a full pelage hair coat during the first week after birth (McGowan et al. 2002
). This finding was unexpected, as more than half of the
50 known keratin genes are expressed in hair follicle tissue alone, often in overlapping patterns (Langbein et al. 2003
; Tong and Coulombe 2004
). Keratins are intermediate filament-forming proteins, and represent major cellular constituents in complex epithelia. Two types of keratin sequences, I and II, can be distinguished, reflecting a biochemical requirement for both during the multistep assembly reaction that produces a 1012-nm-wide keratin filament (Fuchs 1995
). Type I and II keratin genes are cotranscribed in a pairwise, tissue-type, and differentiation-related fashion, providing useful markers to study epithelia in health and disease (Fuchs 1995
; Omary et al. 2004
). In K17-null mice, pelage hair loss correlates in part with hair shaft fragility, consistent with the major function of structural support shared by all keratins. In addition, abnormal apoptosis occurs in hair bulb tissue, possibly reflecting the novel "prosurvival" role evidenced for select keratins (Oshima 2002
; Coulombe and Wong 2004
). Of note, the pelage skin phenotype of K17-null mice is reversible and strain-dependent, correlating with a compensatory up-regulation in K16 (McGowan et al. 2002
). Here, we show that the untimely apoptosis in hair follicles of K17-null mice, beginning at postnatal day 5 (P5), corresponds to a premature anagencatagen transition. K17-null keratinocytes in primary culture are selectively more sensitive to TNF
-induced apoptosis. We further show that TNF
is required for a timely anagencatagen transition in pelage hair follicles, that TNF
signaling is enhanced in K17-null skin, and finally, that loss of TNF
partially rescues the hair cycling defect of K17-null mice. The interaction between K17 and the death adaptor protein TRADD (TNFR1 [TNF receptor 1]-associated death domain protein) provides further evidence for a functional link between this keratin and TNF
signaling. These findings identify K17, a structural protein, and TNF
, a proinflammatory cytokine, as two novel and interdependent regulators of hair cycling.
| Results |
|---|
|
|
|---|
Four lines of evidence suggest that hair follicles prematurely enter catagen in K17-null mouse skin. First, routine histology conducted at P14 shows that wild-type hair follicles are in anagen, as evidenced by their maximal length and bell-shaped bulb region (Fig. 1B). In contrast, K17-null hair follicles are in catagen, as shown by their shortening and the narrowing and destruction of bulb tissue (Fig. 1B'). Second, TUNEL assay shows the presence of many apoptotic cells in the lowermost portion of involuting hair follicles in K17-null, but not wild-type, skin (Fig. 1CC''). Third, two key markers of the anagencatagen transition, FGF5 and PTHRP, are misregulated in K17-null backskin. The FGF5 mRNA is normally low during early and mid-anagen, begins to rise at approximately P10 in the hair matrix and ORS, and peaks in late anagen (Hebert et al. 1994
). By in situ hybridization, we find that FGF5 is up-regulated in a subset of hair follicles at P7 in K17-null skin, while no signal is detected in wild type (Fig. 1DD''). By Northern analysis, FGF5 is slightly up-regulated at P5, and more so at P7 and P10 in K17-null skin, compared with wild type (Fig. 1E). While FGF5 reaches peak levels at P16 in the control, it has already decreased in K17-null skin (Fig. 1E). The PTHRP mRNA is normally expressed during anagen and is down-regulated at catagen entry (Cho et al. 2003
). In situ hybridization shows that PTHRP is down-regulated at P12 in K17-null hair follicles, while it is still expressed in the ORS of wild-type follicles (Fig. 1FF''). Finally, exit from anagen requires a decrease in cell proliferation in the hair matrix. At P5, we find a significant reduction (
30%) in the frequency of BrdU-positive cells in this region of K17-null hair follicles, relative to wild type (Fig. 1GG''). Altogether, these findings establish that hair follicles prematurely commit to the catagen phase of the hair cycle, starting at P5/P7, in K17-null backskin.
Histology was conducted on backskin tissue at later time points to determine whether additional aspects of hair cycling are affected in K17-null mice. At P20, wild-type and K17-null hair follicles are in telogen and early anagen, respectively (data not shown). At P22, wild-type follicles are still in telogen (Muller-Rover et al. 2001
), whereas K17-null follicles have progressed further in anagen, as evidenced by the presence of a well-defined bulb (Fig. 1HH'). Coinciding with the ectopic induction of K16 in hair matrix epithelial cells and normalization of the pelage phenotype (McGowan et al. 2002
), the length of the second anagen is not significantly altered in K17-null hair follicles (data not shown). These data suggest that, in the absence of effective compensatory mechanisms, loss of K17 selectively affects the anagencatagen transition of the hair cycle.
The finding that nullifying a single keratin gene perturbs hair cycling was unexpected. To assess whether this defect specifically results from loss of K17, we reintroduced K17 protein in K17-null mice. All aspects of the skin phenotype, including hair fragility, hair cycling defect, and premature apoptosis in hair follicles, are normalized in the K17 replacement mice (Supplementary Fig. 1). This confirms that the hair alterations associated with the K17-null mutation are specifically due to loss of K17 protein.
K17-null keratinocytes are selectively more sensitive to TNF
-mediated apoptosis
To explore the molecular basis of untimely apoptosis in K17-null hair follicles, we examined the response of keratinocytes in primary culture to a Fas-, TNF
-, and TRAIL-induced apoptotic challenge in the presence of cycloheximide (CHX) (Caulin et al. 2000
). Each of these pathways is operational in skin keratinocytes (Wehrli et al. 2000
). Additionally, defects in K8/K18 filaments increase the susceptibility of trophectoderm and adult liver hepatocytes to specific proapoptotic signals including TNF
and FasL, a finding that is reproduced in epithelial cell lines (Caulin et al. 2000
; Gilbert et al. 2001
; Jaquemar et al. 2003
; Ku et al. 2003
). In the context of primary culture, newborn mouse skin keratinocytes express K17 and K14 uniformly, and K16 in a patchy fashion (Wawersik and Coulombe 2000
). Expression of K17 and K16 in this setting likely reflects the elaboration of a wound repair program in serum-exposed keratinocytes (Weiss et al. 1984
).
Treatment with dimethyl sulfoxide (DMSO) (CTL) produced very little apoptosis over 24 h in wild-type and K17-null keratinocytes (Fig. 2A,B,C, C'). Of all the treatment combinations tested, TNF
and TRAIL gave rise to a greater degree of apoptosis. K17-null cells (24.1 ± 3.5%) showed more apoptosis than wild type (15.8 ± 0.9%) in response to TNF
(Fig. 2A,B). This difference was obvious in TUNEL-stained preparations (Fig. 2CD'). No difference was observed for any other treatment (Fig. 2A,B), and following UVB exposure (data not shown). This differential TNF
responsiveness is likely underestimated since (1) these cultures contain mostly epidermis-derived, instead of hair follicle-derived, keratinocytes (Marcelo et al. 1978
); and (2) K14 and K16 are expressed as well, raising the prospect of phenotypic rescue in the setting of primary culture (see below).
|
/CHX treatment. A greater fraction of K17-null keratinocytes (31.5 ± 2.0%) showed apoptosis under these conditions (Fig. 2E), likely owing to the stress of lipofectamine-mediated transfection. Neighboring K17-re-expressing keratinocytes showed significantly less apoptosis (18.2 ± 2.3%; p < 0.001), as expected (Fig. 2E). Together, these findings show that loss of K17 cell-autonomously increases the susceptibility of cultured skin keratinocytes to TNF
-mediated apoptosis, suggesting that such may be the case as well in vivo.
K17 interacts with TRADD, a death adaptor, in mouse skin keratinocytes
That K17, a cytoskeletal protein, influences the responsiveness of keratinocytes to TNF
is a priori surprising. The previously documented interaction between K18 and TRADD (Inada et al. 2001
), a death adaptor protein essential for signal relay downstream from TNF receptor 1 (TNFR1) (Micheau and Tschopp 2003
), provides a possible mechanism. Inada et al. (2001)
found that the K18TRADD interaction affords a protection against TNF
-induced apoptosis, possibly via the sequestration of TRADD away from TNFR1. TRADD also binds K14 in a human keratinocyte cell line (Yoneda et al. 2004
). Mapping studies showed that TRADD binds the 1A subdomain in K18 (Inada et al. 2001
) and K14 (Yoneda et al. 2004
), a region that is highly conserved in other type I keratins. The physiological significance of these interactions in vivo is unknown.
Coimmunoprecipitation assays using two distinct antibodies revealed that, as expected, K17, K16, and K14 are present in endogenous TRADD immunoprecipitates obtained from primary cultures of mouse skin keratinocytes (Fig. 3A, A'). In mouse keratinocytes transfected with GFP fusion constructs, both full-length TRADD (residues 1312) (Fig. 3BB'') and its C-terminal moiety (residues 105312) (Fig. 3CC'') partially colocalize with K17 in the cytoplasm. Similar results were obtained in preparations double-stained for K14 and TRADD (data not shown). In contrast, the N terminus of TRADD (residues 1105) shows a diffuse distribution in the cytoplasm and nucleus (data not shown). Partial colocalization between TRADD, a signaling adaptor present at low levels, and the abundant K17 does not preclude a physiologically relevant interaction. The finding that TRADD potentially interacts with K14 and K16 in vivo is significant, as K16 has been implicated in the reversibility and strain-dependence of the hair phenotype in K17-null mice (McGowan et al. 2002
). Additional studies are required to ascertain whether altered regulation of TRADD is, indeed, involved in the increased susceptibility of K17-null keratinocytes to TNF
-induced apoptosis.
|
signaling contributes to hair cycle regulation in vivo
There is as yet no definitive evidence implicating the TNF
/TNFR1 signaling pathway in mature hair follicles of postnatal mouse skin. Several conditions need to be met to support the possibility that TNF
/TNFR1 play a role in hair cycling, and specifically, in the defect exhibited by K17-null mice: (1) Key pathway components such as TNFR1 and TRADD should be coexpressed with K17 in follicles (consistent with a cell-autonomous mechanism); (2) inactivation of this pathway should delay the anagencatagen transition in otherwise normal skin; (3) TNF
/TNFR1-dependent signaling should be enhanced in K17-null skin; and (4) abrogation of TNF
should ameliorate if not rescue the hair cycling defect in K17-null skin.
We first sought to determine whether TNFR1 and TRADD are expressed in K17-expressing keratinocytes within hair follicles (Fig. 4A, A'). This is a prerequisite for a cell-autonomous, K17-dependent modulation of TNFR1/TRADD signaling in hair tissue. Using in situ hybridization, we found that both TNFR1 (Fig. 4B, B') and TRADD (Fig. 4C, C') mRNAs occur in the hair matrix and ORS compartments of anagen-stage wild-type follicles, in a pattern that overlaps significantly with that of K17 (Fig. 4A, A').
|
/TNFR1-dependent signaling during normal hair cycling through monitoring I
B
mRNA levels between P5 and P28 in wild-type mouse skin. The I
B
gene is a direct transcriptional target of NF-
B, which is activated following the engagement of TNFR1 (Hoffmann et al. 2002
B
mRNA occurs at low levels between P5 and P14, when follicles are in anagen (Fig. 4D, D'). Near the point of catagen entry (approximately P16), its level rises and reaches a plateau that is maintained between P18 and P22. At P25, near the onset of the next anagen phase, I
B
mRNA levels have returned to precatagen levels (Fig. 4D, D'). In light of our finding of delayed catagen entry in mice lacking TNF
(see below), the hair cycle dependency of I
B
regulation, at the mRNA level, likely reflects parallel fluctuations in TNFR1 signaling in vivo. By comparison, K17 protein is regulated in a reciprocal fashion during hair cycling: Its level increases progressively during anagen in wild-type backskin, reaching peak levels between P12 and P16, but is markedly reduced during catagen and telogen (between P18 and P25) (Fig. 4E). K17 levels reincrease at P28, coinciding with the next anagen (Fig. 4E). These findings significantly extend previous studies focusing on K17 mRNA (Panteleyev et al. 1997
/TNFR1-dependent signaling during anagen in pelage hair follicles.
Next, we analyzed C57Bl/6 mice null for the TNF
gene to assess whether the loss of this cytokine impacts hair follicle cycling. TNF
-null mice are viable and do not exhibit an obvious phenotype unless immunologically challenged (Pasparakis et al. 1996
). Histologically, we find that TNF
-null hair follicles show a delayed entry into catagen. At P16, hair follicles are still in anagen in TNF
-null backskin, whereas they have already initiated catagen, as expected, in control TNF
+/ littermates (Fig. 4F, F'). Accordingly, no apoptosis can be detected in TNF
-null hair follicles at P16 (Fig. 4G', G''), while controls showed significant TUNEL staining and narrowing in the bulb region (Fig. 4G). The morphological findings are substantiated by Northern analyses. Thus, higher levels of two markers of late anagen, FGF5 and PTHRP, occur at P16 in TNF
-null skin, relative to control (Fig. 4H,I). Conversely, the mRNAs for two direct NF-
B target genes, I
B
and c-FLIP (Kreuz et al. 2001
), are decreased at P14, and especially at P16 (by twofold), in TNF
-null skin (Fig. 4H,I), providing further evidence that NF-
B activity is a reliable indicator of TNF
/TNFR1 activity in mouse postnatal skin. These findings establish that loss of TNF
causes a modest but consistent delay in catagen entry in mouse backskin (by
1.5 d, based on histology), thus revealing a previously unknown role for this cytokine in hair cycling. Since the ablation of FGF5, so far defined as the most significant signal in this context, delays catagen entry by only
23 d (Hebert et al. 1994
), the finding that loss of TNF
does not abrogate this key step altogether could be anticipated.
Alteration in NF-
B activity in K17-null skin
Although subject to a complex regulation in response to engagement of receptors other than TNFR1 (Moynagh 2005
), the findings reported above suggest that NF-
B activity can be used as an indicator of TNF
-dependent signaling in mouse postnatal skin. To assess NF-
B activity at the time of phenotype onset in K17-null skin, we examined the expression of several of its target genes. By Northern analysis, the I
B
mRNA level is increased by 40% at P5 and 80% at P7 in K17-null tissue relative to controls (Fig. 5A). The c-FLIP mRNA level is increased by 20% and 70% at P5 and P7, respectively, in K17-null tissue (Fig. 5B). Greater increases, that is, 120% at P5 and 135% at P7, occur for yet another well-known NF-
B target gene, ICAM-1 (Fig. 5C; Kondo and Sauder 1997
; Min et al. 2005
). In situ hybridization studies, conducted at P7, showed that I
B
(Fig. 5D'), c-FLIP (Fig. 5E'), and ICAM-1 mRNAs (Fig. 5F') are markedly elevated in the matrix and ORS in a subset of hair follicles in K17-null skin, thereby enhancing the significance of the Northern findings. Only weak hybridization for these mRNAs was detected in control skin tissue (Fig. 5DF). Next, we performed subcellular fractionation of backskin tissue coupled with Western analysis to assess translocation of p65 (relA) to its site of action, the nucleus (Scott et al. 1993
). Coinciding with the increased expression of NF-
B target genes starting at P5, there is a significant increase in nuclear relA (p65) along with a decrease in cytoplasmic levels of I
B
protein in K17-null skin relative to the control (Fig. 5G). RelA (p65) could not be localized in mouse skin owing to a lack of antibodies suitable for immunostaining of tissue sections (our unpublished data).
|
B activation, TNF
also cause phosphorylation and activation of JNK (Zhang et al. 2004
Loss of TNF
can partially rescue the apoptotic phenotype of K17-null hair follicles
The model suggested by our findings predicts that the hair cycling defect in K17-null mice should be normalized, to some degree, by loss of TNF
. To put this notion to a stringent test, we generated double-null mice (K17/ TNF
/) in the C57Bl/6 strain background. Several parameters were assessed, between P7 and P14, in the 29 K17/ TNF
/ mice produced for analysis (Table 1). A significant fraction of K17/ TNF
/ mice (31%) showed no apoptosis (Fig. 6CC') in their pelage follicles, correlating with well-developed, bell-shaped hair bulbs characteristic of anagen-stage follicles (Fig. 6BB'). Similarly,
34% of the K17/ TNF
/ mouse samples analyzed by in situ hybridization showed low levels of FGF5 mRNA, as is the case in wild-type mice (Fig. 6DD'; Table 1). In both instances, the difference between K17/ TNF
/ and K17/ TNF
+/+ mice reached a high degree of statistical significance (Table 1), establishing the occurrence of a genetic interaction. Despite rescue of the hair cycle defect, only two K17/ TNF
/ mice showed a normal hair coat (e.g., Fig. 6A; Table 1). Consistent with the latter, all K17/ TNF
/ mice had fragile hair shafts (Table 1). Apoptosis and hair fragility thus represent independent phenomena in K17-null skin.
|
|
| Discussion |
|---|
|
|
|---|
. Expression of K17 protein, or a functional equivalent (e.g., K16) (McGowan et al. 2002
, on the other hand, is required for the timely occurrence of the anagencatagen transition. We provide genetic evidence that K17 modulates the function of TNF
in the specific context of hair cycling, and biochemical evidence (albeit indirect) that TNF
signaling is enhanced in K17-null mouse skin tissue. That a keratin structural protein contributes to hair cycle regulation, and does so independently of its structural support role in epithelia, was unexpected and represents an exciting new direction for skin biology.
Unlike the case for keratins, a role in hair morphogenesis, and possibly in hair cycling as well, has already been defined for a TNF superfamily member, ectodysplasin (Eda), acting through its receptor Edar (Thesleff and Mikkola 2002
). Although they affect hair growth in opposing ways, the catagen inducer TNF
(this study; see Ruckert et al. 2000
) and anagen promoter ectodysplasin (Mustonen et al. 2003
) share NF-
B as a major intracellular target. In this study, NF-
B was used as a readout for TNF
/TNFR1-dependent signaling at the anagencatagen transition in wild-type, K17-null, and TNF
-null skin. The data derived from TNF
-null skin at P14/P16, in particular, indicate that NF-
B activity reliably reports on the loss of this cytokine. Our studies do not directly address the issue of NF-
Bs role in this setting. Zhang et al. (2004)
elegantly described how the RelA (p65) subunit of NF-
B antagonizes a strong TNFR1-dependent proliferation signal during normal homeostasis in human epidermis reconstituted by grafting in mouse skin. These findings (see also Gugasyan et al. 2004
) cemented the notion that NF-
Bs antiproliferative influence in mature epidermis is unique compared with many other tissues (Bolotin and Fuchs 2003
) including developing hair follicles (Schmidt-Ullrich et al. 2001
). Given a reduced mitotic activity of hair matrix epithelial cells in K17-null skin at P5, activation of NF-
B could act to slow down their proliferation at the end of anagen, as is the case in human epidermis (Zhang et al. 2004
), while another signal would be required for commitment to apoptosis and catagen entry. While there is evidence that TNFR1-mediated apoptosis of epidermal keratinocytes in culture requires reduced NF-
B activity (see Qin et al. 2001
; Basile et al. 2003
; Konur et al. 2005
), how the latter impacts the proliferation, differentiation, and/or apoptosis of this cell type is clearly a function of the global signaling environment (e.g., Poppelmann et al. 2005
).
K17s ability to interact with TRADD provides an attractive, yet unproven mechanism to account for the genetic interaction between K17 and TNF
in hair follicles. First, there is a precedent for modulation of TNF
signaling in a keratin/TRADD-dependent fashion. Inada et al. (2001)
showed a reverse correlation between the levels of K18, which binds TRADD directly, and susceptibility of epithelial cell lines to TNF
-induced apoptosis. These authors proposed a cell-autonomous mechanism, keratin-dependent sequestration of TRADD, to account for this effect. Jaquemar et al. (2003)
showed that loss of maternally derived TNF
significantly increases the viability of K8-null embryos (such embryos lack K8s partner protein K18 as well), although the mechanism involved may be distinct. Second, the conserved property of interacting with TRADD could account for the ability of K16 (and possibly K14) to prevent, in an age- and strain-specific fashion, the hair cycling defect in K17-null hair follicles (McGowan et al. 2002
). Third, TRADD participates to signal relay from receptors other than TNFR1, such that loss of the K17TRADD interaction could also account for the fraction of the hair cycling defect that cannot be explained solely by TNF
signaling in K17-null mice (Table 1). As an example, IFN-
signals in a STAT1
- and TRADD-dependent fashion (Wesemann et al. 2004
) and is also required for the timely occurrence of the anagencatagen transition in mouse hair follicles (Hirota et al. 2002
, 2003
). TNF
, IFN-
, and IL-1
cause significantly more apoptosis in mouse pelage hair follicles when administered intradermally together, rather than individually (Ruckert et al. 2000
). In an apparent paradox, TRADDs adaptor function is essential to both the proapoptotic (DISC complex-dependent) and prosurvival (NF-kB-dependent) arms of TNF
signal relay (Micheau and Tschopp 2003
), raising the concern that a simple TRADD sequestration model cannot mediate K17s influence on TNF
signaling. This said, the level of intact c-FLIP protein is markedly reduced in K17-null skin (in contrast to its mRNA), suggesting that the NF-
B-dependent arm of the TNF
signal relay is subject to additional regulation. Clearly, development of suitable reagents and cellular models is needed to confirm the functional role of the keratinTRADD interaction in TNF
-treated keratinocytes, and explore alternative mechanisms.
A genetic approach can help toward further dissection of the hair cycling defect in K17-null mice. We have obtained evidence that one or more loci located proximal to the type I keratin gene cluster also modulate the impact of K17 loss. All the findings we report here involved progeny from the sixth and seventh backcrosses (N6, N7) of K17-null allele carriers into the C57Bl/6 strain. The complete penetrance of the pelage hair phenotype observed under such conditions is eroded, however, with further backcrossing. When N12 K17+/ mice are interbred, only
25% of the K17/ progeny show a hair loss phenotype, implying a powerful modulatory role for modifier gene(s) located proximal to the K17 locus. The average amount of genomic DNA flanking an allele of interest changes from
30 cM to
20 cM from N6 to N12 (Peirce 2001
; Olofsson and Holmdahl 2003
). Intriguingly, there is a cluster of cytokine-encoding genes located
2930 cM away from the K17 locus (11D; 11 58.7 cM) on mouse chromosome 11 (Wilson et al. 1990
; Wenderfer et al. 2000
). These include genes for IL-3, IL-4, IL-5, IL-13, interferon regulatory factor 1, granulocyte-macrophage colony-stimulating factor, and a few others. In light of the role of TNF
(this study) and IFN-
(Hirota et al. 2002
, 2003
) in regulating catagen entry in hair follicles, it makes sense that additional proinflammatory genes might impact the penetrance of the K17-null mutation. Identifying these genes, the cellular source of their protein products, and the mechanisms through which they act, should provide novel insight into hair cycling.
| Materials and methods |
|---|
|
|
|---|
The K17-null mice (McGowan et al. 2002
) used in this study were backcrossed into the C57Bl/6 mouse strain for six or seven generations (N6, N7). TNF
-null mice, backcrossed in the C57Bl/6 strain, were a gift from Dr. M. Meffert (Johns Hopkins University, Baltimore, MD). K17-TNF
double-null mice were created by mating the two single-knockout strains. Genotyping was done by PCR from mouse tail genomic DNA as described (McGowan et al. 2002
). Genotyping at the TNF
locus was done by PCR, as follows: denaturation at 94°C for 1 min; annealing at 62°C for 1 min; elongation: 72°C for 1 min, using the following primer pairs: null TNF
allele (forward, 5'-AGCCAACCAG GCAGGTTCTG-3'; and reverse, 5'-CCTTCTATCGCCTTCT TGACGAG-3') and wild-type allele (forward, 5'-AGCCAACC AGGCAGGTTCTG-3'; and reverse, 5'-TAGACAGAAGAGCG TGGTGG-3'). Mice were provided rodent chow and water ad libitum. All protocols were approved by the institutional Animal Care and Use Committee.
Primary antibodies
The following primary antibodies were used: rabbit polyclonal antisera against K17 (McGowan and Coulombe 1998
), K16 (Bernot et al. 2002
), K14 (Covance), c-FLIP (Upstate Biotechnology), TRADD (Santa Cruz Biotechnology), TRADD (provided by Dr. Masaki Inagaki, Aichi Cancer Research Institute, Nagoya, Japan) (Inada et al. 2001
), I
B
(Santa Cruz Biotechnology), p65 (Santa Cruz Biotechnology), and lamin B (provided by Dr. Kathy Wilson, Johns Hopkins University, Baltimore, MD) (Zastrow et al. 2006
), and mouse monoclonal antibodies to K10, BrdU,
-tubulin, and actin (Sigma).
Tissue harvesting, histological analyses, and BrdU labeling
For studies of hair cycling, skin tissue was always obtained from the mid-back region of age- and gender-matched mouse littermates. For histology, tissues were fixed in Bouins (12 h, 4°C) prior to paraffin embedding. Five-micrometer sections were counterstained with hematoxylin and eosin. Alternatively, fresh-frozen tissues were embedded in OCT (Sakura Finetec) and 10-µm sections were immunostained using the primary antibodies described above, followed by FITC- or Rhodamine-conjugated secondary antibodies (Kirkegaard and Perry Laboratories) (Bernot et al. 2004
). TUNEL (Roche) and Hoechst (Sigma) stainings were performed on 4% paraformaldehyde-fixed, paraffin-embedded samples following the manufacturers instructions (McGowan et al. 2002
). For BrdU labeling, five P5 mice of each genotype were intraperitoneally injected with BrdU (20 mg/kg body weight; Sigma) and sacrificed after 45 min. Ten-micrometer-thick cryosections were fixed for 10 min in 10% formalin, PBS-washed, and stained with anti-BrdU (Sigma) as described (Paladini and Coulombe 1998
). For each genotype, BrdU-labeled cells were counted in 50 hair bulbs (sectioned through dermal papillae) from 10 sections. The hair bulb area was measured with MacBAS version 2.5 software (Fuji Medical Systems USA). Data are presented as the average numbers of BrdU-positive cells per surface area of bulb tissue.
In situ hybridization and Northern blot analysis
Detailed protocols for in situ hybridization and Northern blot analyses were described (McGowan et al. 2002
; Tong and Coulombe 2004
). The probes used in this study included FGF5, FGFR2 (both provided by Dr. G. Martin, University of California at San Francisco, CA),
-tubulin, PTHRP (provided by Dr. C. Thompson, Johns Hopkins University, Baltimore, MD), c-FLIP and ICAM-1 (ordered from ATCC), I
B
(provided by Dr. L. Lin, Johns Hopkins University, Baltimore, MD), TRADD (generated by RTPCR; forward primer, 5'-CTGCGGTAGACAAGGTGA TCC-3'; reverse primer, 5'-CAGTACTAGACTTAGGCCAG GC-3'), TNFR1 (generated by RTPCR; forward primer, 5'-GCC CCCACCTCTGTTCAGAAATG-3'; reverse primer, 5'-GTTG TGGGTGTGGCTTTATCGC-3'). Northern blots were imaged and quantitated using a Fujifilm BAS-2500 PhosphorImager. Values were normalized to signal for
-tubulin. Each Northern analysis was conducted at least two times, with similar findings.
Keratinocyte cultures and their analysis
Primary keratinocytes were collected from P2/P3 mouse littermates (wild type or K17 null), plated, and cultured as described (Bernot et al. 2004
). Transient transfections were carried out using Lipofectamine 2000 (Invitrogen) using the manufacturers instructions. After 48 h, cultures were fixed with 4% paraformaldehyde, permeabilized with methanol, and processed for indirect immunofluorescence labeling (Bernot et al. 2004
). Studies involving proapoptotic treatments were conducted at 48 h after plating. Cultures were treated for 24 h with DMSO vehicle control (CTL), 5 µg/mL CHX, as well as 50 µg/mL Jo2 (the agonistic antibody to FAS ligand) (Gilbert et al. 2001
), 100 ng/mL TNF
, 5 µg/mL TRAIL in the presence of 5 µg/mL CHX. TUNEL (Roche) and Hoechst (Sigma) stainings were performed on 4% paraformaldehyde-fixed, 0.1% Triton X-100-permeablized cultured cells, to identify apoptotic cells. Alternatively, caspase activity (activated caspases 2, 3, 6, 7, 8, 9, and 10) was quantified by fluorimetry as follows: At 24 h after induction of apoptosis, caspase substrate (Roche) diluted in lysis buffer was added to each well and incubated for 2 h at 37°C. Substrate cleavage was measured using a PerkinElmer HTS 7000 Plus spectrofluorometer, with excitation and emission wavelengths set at 485 and 535 nm, respectively, as recommended (Roche). A calibration curve obtained using free Rhodamine-110 fluorochrome was used for calculating values for each sample. In separate studies, the frequency of apoptotic cells after TNF
treatment was determined in primary cultures of K17-null keratinocytes transfected with wild-type K17. Transient transfection was done at 12 h after plating using lipofectamine 2000 according to the manufacturers instructions (Invitrogen). Proapoptotic treatment (100 ng/mL TNF
+ 5 µg/mL CHX) was performed at 48 h after plating. At 24 h later, cells were subjected to immunofluorescence labeling for K17 followed by TUNEL staining. In separate transfection studies, the GFP-TRADD fusion constructs were provided by Dr. Andrew Thorburn (Wake Forest University, Winston-Salem, NC) (Bender et al. 2005
).
Immunoprecipitation and Western blot analysis
Wild-type skin keratinocytes in primary culture were solubilized with 2% Empigen BB (Calbiochem) buffer. Protein A-Sepharose beads (Amersham Biosciences) were washed with PBS, conjugated to rabbit antibody against TRADD or normal rabbit serum, then added with an equal volume of cell lysate and incubated for 12 h at 4°C (Bernot et al. 2004
). After three washes (2% Empigen BB buffer), bound protein was eluted with 5x gel sample buffer containing
-mercaptoethanol. Eluted proteins were subjected to SDS-PAGE and Western blot analysis. Western blot analysis of protein extracts from depilated skin or clipped hair was performed as described (McGowan et al. 2002
; Bernot et al. 2004
). For quantification, NIH image software was used as described (Paladini and Coulombe 1998
).
Cell fractionation
Nuclear and cytoplasmic extracts were prepared according to Lammerding et al. (2004)
, with modifications. Skin samples were cut into small pieces and homogenized in ice-cold buffer A (0.1% Triton X-100, 10 mM EDTA, 10 mM EGTA, 10 mM KCl, 10 mM HEPES, 1 mM DTT, 0.5 mM PMSF, protease inhibitor cocktail) on ice for 1 min. The homogenate was spun (16,000g, 5 min, 4°C). The supernatant was stored as the cytoplasmic fraction. Nuclei-containing pellets were washed in ice-cold PBS and incubated in ice-cold buffer B (1 mM EDTA, 1 mM EGTA, 0.4 M NaCl, 20 mM HEPES, 5 mM MgCl2, 25% glycerol, 1 mM DTT, 0.5 mM PMSF, protease inhibitor cocktail) at 4°C for 30 min with mixing. The nuclear extract was centrifuged (16,000g, 10 min, 4°C), and the supernatant was stored as the nuclear fraction. The nuclear and cytoplasmic fractions were subjected to SDS-PAGE and Western blot analysis. Fraction purity was verified by immunoblotting for tubulin (cytoplasmic) and lamin B (nuclear) antigens.
| Acknowledgments |
|---|
|
|
|---|
-null mice, reagents, and advice; Drs. Gail Martin, Masaki Inagaki, Li Lin, and Andrew Thorburn for providing reagents; and Drs. Joel Pomerantz, Michael Caterina, Roger Reeves, Susan Craig, Catherine Thompson, and Katherine Wilson for reagents and/or advice. This work was supported by NIAMS/NIH grant AR44232 to P.A.C. | Footnotes |
|---|
E-MAIL coulombe{at}jhmi.edu; FAX (410) 614-7567. ![]()
Supplemental material is available at http://www.genesdev.org.
Article and publication are at http://www.genesdev.org/cgi/doi/10.1101/gad.1387406
| References |
|---|
|
|
|---|
B-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor
induces growth arrest and cytoprotection in normal human keratinocytes. Mol. Cancer Res. 1: 262270.Beaudoin G.M. III, Sisk J.M., Coulombe P.A., Thompson C.C. 2005. Hairless triggers reactivation of hair growth by promoting Wnt signaling. Proc. Natl. Acad. Sci. 102: 1465314658.
Bender L.M., Morgan M.J., Thomas L.R., Liu Z.G., Thorburn A. 2005. The adaptor protein TRADD activates distinct mechanisms of apoptosis from the nucleus and the cytoplasm. Cell Death Differ. 12: 473481.[CrossRef][Medline]
Bernot K., McGowan K., Coulombe P.A. 2002. Keratin 16 expression defines a subset of epithelial cells during skin morphogenesis and the hair cycle. J. Invest. Dermatol. 119: 11371149.[CrossRef][Medline]
Bernot K.M., Coulombe P.A., Wong P. 2004. Skin: An ideal model system to study keratin genes and proteins. Methods Cell Biol. 78: 453487.[Medline]
Bolotin D. and Fuchs E. 2003. Cancer: More than skin deep. Nature 421: 594595.[CrossRef][Medline]
Caulin C., Ware C.F., Magin T.M., Oshima R.G. 2000. Keratin-dependent, epithelial resistance to tumor necrosis factor-induced apoptosis. J. Cell Biol. 149: 1722.
Cho Y.M., Woodard G.L., Dunbar M., Gocken T., Jimenez J.A., Foley J. 2003. Hair-cycle-dependent expression of parathyroid hormone-related protein and its type I receptor: Evidence for regulation at the anagen to catagen transition. J. Invest. Dermatol. 120: 715727.[CrossRef][Medline]
Cotsarelis G. and Millar S.E. 2001. Towards a molecular understanding of hair loss and its treatment. Trends Mol. Med. 7: 293301.[CrossRef][Medline]
Coulombe P.A. and Wong P. 2004. Cytoplasmic intermediate filaments revealed as dynamic and multipurpose scaffolds. Nat. Cell Biol. 6: 699706.[CrossRef][Medline]
Foitzik K., Lindner G., Mueller-Roever S., Maurer M., Botchkareva N., Botchkarev V., Handjiski B., Metz M., Hibino T., Soma T. et al. 2000. Control of murine hair follicle regression (catagen) by TGF-
1 in vivo. FASEB J. 14: 752760.
Fuchs E. 1995. Keratins and the skin. Annu. Rev. Cell Dev. Biol. 11: 123153.[CrossRef][Medline]
Fuchs E., Merrill B.J., Jamora C., DasGupta R. 2001. At the roots of a never-ending cycle. Dev. Cell 1: 1325.[CrossRef][Medline]
Gilbert S., Loranger A., Daigle N., Marceau N. 2001. Simple epithelium keratins 8 and 18 provide resistance to Fas-mediated apoptosis. The protection occurs through a receptor-targeting modulation. J. Cell Biol. 154: 763774.
Gilbert S., Loranger A., Marceau N. 2004. Keratins modulate c-Flip/extracellular signal-regulated kinase 1 and 2 antiapoptotic signaling in simple epithelial cells. Mol. Cell. Biol. 24: 70727081.
Gugasyan R., Voss A., Varigos G., Thomas T., Grumont R.J., Kaur P., Grigoriadis G., Gerondakis S. 2004. The transcription factors c-rel and RelA control epidermal development and homeostasis in embryonic and adult skin via distinct mechanisms. Mol. Cell. Biol. 24: 57335745.
Hadshiew I.M., Foitzik K., Arck P.C., Paus R. 2004. Burden of hair loss: Stress and the underestimated psychosocial impact of telogen effluvium and androgenetic alopecia. J. Invest. Dermatol. 123: 455457.[CrossRef][Medline]
Hardy M.H. 1992. The secret life of the hair follicle. Trends Genet. 8: 5561.[Medline]
Hebert J.M., Rosenquist T., Gotz J., Martin G.R. 1994. FGF5 as a regulator of the hair growth cycle: Evidence from targeted and spontaneous mutations. Cell 78: 10171025.[CrossRef][Medline]
Hirota R., Tajima S., Yoneda Y., Tamayama T., Watanabe M., Ueda K., Kubota T., Yoshida R. 2002. Alopecia of IFN-
knockout mouse as a model for disturbance of the hair cycle: A unique arrest of the hair cycle at the anagen phase accompanied by mitosis. J. Interferon Cytokine Res. 22: 935945.[CrossRef][Medline]
Hirota R., Tajima S., Yoneda Y., Okada M., Tashiro J., Ueda K., Kubota T., Yoshida R. 2003. Induction of hair regrowth in the alopecia site of IFN-
knockout mice by allografting and IFN-
injection into the transplantation site. J. Interferon Cytokine Res. 23: 433439.[CrossRef][Medline]
Hoffmann A., Levchenko A., Scott M.L., Baltimore D. 2002. The I
B-NF-
B signaling module: Temporal control and gene activation. Science 298: 12411245.
Inada H., Izawa I., Nishizawa M., Fujita E., Kiyono T., Takahashi T., Momoi T., Inagaki M. 2001. Keratin attenuates tumor necrosis factor-induced cytotoxicity through association with TRADD. J. Cell Biol. 155: 415426.
Jamora C., DasGupta R., Kocieniewski P., Fuchs E. 2003. Links between signal transduction, transcription and adhesion in epithelial bud development. Nature 422: 317322.[CrossRef][Medline]
Jaquemar D., Kupriyanov S., Wankell M., Avis J., Benirschke K., Baribault H., Oshima R.G. 2003. Keratin 8 protection of placental barrier function. J. Cell Biol. 161: 749756.
Kondo S. and Sauder D.N. 1997. Tumor necrosis factor (TNF) receptor type 1 (p55) is a main mediator for TNF-
-induced skin inflammation. Eur. J. Immunol. 27: 17